Mark T. W. Ebbert, PhD Linkedin Twitter Google Mark Ebbert, Ph.D., studies neurodegenerative diseases using cutting-edge sequencing technologies and computational approaches such as computational biology and bioinformatics. Dr. Ebbert’s research focuses primarily on Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease). Ultimately, Dr. Ebbert aims to discover disease etiology and develop […]
Susanne Wegmann, PhD Linkedin Google Proteins are the ‘work horses’ of cells and enable almost all cellular functions, from genome organization over signaling cascades up to the mechanical support of cellular structures and transport of molecules. Neurons are especially polarized non-dividing cells with extreme extensions and diverse microenvironments, which asks for robustly regulated and highly
Albert (Gus) Davis, MD, PhD Twitter I am a neurologist and neuroscientist with interests in neurodegenerative diseases, protein aggregation, and mechanisms underlying neuron injury and death. My long term goal is to better understand the molecular events that influence the pathological aggregation of disease-associated proteins contributing to dementia in Alzheimer disease (AD) and Parkinson disease
Zvinka Zlatar, PhD Linkedin Google Dr. Zlatar received her PhD in clinical psychology from the University of Florida, with a focus on adult neuropsychology/geropsychology. She completed her APA-accredited clinical psychology internship at the University of California, Los Angeles (Semel Institute for Neuroscience and Human Behavior), focusing on the neuropsychological assessment of older adults and Spanish-speaking
Cristian Lasagna-Reeves, PhD Linkedin Twitter Facebook Google My scientific career has revolved around the study of protein aggregation in neurodegenerative diseases. To investigate the mechanism of these diseases, I have used a broad range of strategies, such as in Vitro aggregation assays with recombinant protein, disease cellular models, mouse genetic interaction experiments, behavioral studies, and
Cristian Lasagna-Reeves Read More »
Robert Hill, PhD Linkedin Twitter Google The Hill lab at Dartmouth uses high-resolution optical imaging approaches to investigate how diverse cell populations dynamically interact in the brain. We develop and implement new techniques that allow visualization and manipulation of these distinct cell types in their native environment. For the 2017 Charleston Conference on Alzheimer’s Disease
Clement Y. Chow, PhD Linkedin Twitter Facebook Google The genetic variation found in natural populations is a rich unbiased resource for identifying novel elements of biological pathways. Variation is often exploited to study adaptive traits but remains under-utilized in the study of disease modifiers and pathways. Understanding how a particular pathway varies within a population
Alan Renton, PhD Google Dr. Renton’s expertise is the generation and analysis of genomic and functional data to identify and characterize neurodegenerative disease genes. His interests have encompassed a range of disorders, specifically Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Parkinson’s disease (PD), and progressive supranuclear palsy (PSP). His ongoing and future
Susanne Van Veluw, PhD Linkedin Twitter Google Dr. Van Veluw is interested in the vascular contributions to dementia, and have a strong background in neuroimaging and neuropathology. Her current research focuses on one of the most common age-related cerebral small vessel diseases; cerebral amyloid angiopathy (CAA). She use both in vivo clinical MRI as well
Jason Ulrich, PhD Linkedin Dr. Ulrich is an Assistant Professor in Neurology at Washington University in St. Louis. He began working in the field of Alzheimer’s disease (AD) after obtaining his PhD in Pharmacology at the University of Iowa. During his post-doctoral training with David Holtzman at Washington University he became interested in the role
